Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: A pooled analysis of 26 epidemiological studies

The Lancet Oncology

Volumn 12, Issue 11, 2011, Pages 1023-1031

  Castellsagué, Xavier ^a,d   Díaz, Mireia ^a   Vaccarella, Salvatore ^b   de Sanjosé, Silvia ^a,d   Muñoz, Nubia ^a   Herrero, Rolando ^b   Franceschi, Silvia ^b   Meijer, Chris J L M ^c   Bosch, F Xavier ^a,e  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^e Network on Cooperative Cancer Research (RTICC)   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADENOSQUAMOUS CARCINOMA; ADULT; ARTICLE; CANCER PREVENTION; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; ENDOMETRIUM CARCINOMA; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INFECTION RISK; INTERVIEW; INTRAUTERINE CONTRACEPTIVE DEVICE; MAJOR CLINICAL STUDY; NONHUMAN; PAPANICOLAOU TEST; POPULATION RESEARCH; PRIORITY JOURNAL; RISK REDUCTION; UTERINE CERVICITIS; UTERINE CERVIX CARCINOMA; VERRUCA VULGARIS; WART VIRUS;

ADULT; DNA, VIRAL; FEMALE; HUMANS; INTRAUTERINE DEVICES; LOGISTIC MODELS; MIDDLE AGED; ODDS RATIO; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTORS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; WOMEN'S HEALTH; YOUNG ADULT;

EID: 80053385768     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(11)70223-6     Document Type: Article

References (37)

1. Beining RM, Dennis LK, Smith EM, Dokras A Meta-analysis of intrauterine device use and risk of endometrial cancer. Ann Epidemiol 2008, 18:492-499.
2. Castellsague X, Thompson WD, Dubrow R Intra-uterine contraception and the risk of endometrial cancer. Int J Cancer 1993, 54:911-916.
3. Curtis KM, Marchbanks PA, Peterson HB Neoplasia with use of intrauterine devices. Contraception 2007, 75(suppl 6):60-69.
4. Hubacher D, Grimes DA Noncontraceptive health benefits of intrauterine devices: a systematic review. Obstet Gynecol Surv 2002, 57:120-128.
5. Lassise DL, Savitz DA, Hamman RF, Baron AE, Brinton LA, Levines RS Invasive cervical cancer and intrauterine device use. Int J Epidemiol 1991, 20:865-870.
6. Castellsague X, Diaz M, de Sanjose S, et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst 2006, 98:303-315.
7. Pham TH, Nguyen TH, Herrero R, et al. Human papillomavirus infection among women in South and North Vietnam. Int J Cancer 2003, 104:213-220.
8. Sukvirach S, Smith JS, Tunsakul S, et al. Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand. J Infect Dis 2003, 187:1246-1256.
9. Shin HR, Lee DH, Herrero R, et al. Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer 2003, 103:413-421.
10. Dai M, Bao YP, Li N, et al. Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study. Br J Cancer 2006, 95:96-101.
11. Wu RF, Dai M, Qiao YL, et al. Human papillomavirus infection in women in Shenzhen City, People's Republic of China, a population typical of recent Chinese urbanisation. Int J Cancer 2007, 121:1306-1311.
12. Li LK, Dai M, Clifford GM, et al. Human papillomavirus infection in Shenyang City, People's Republic of China: a population-based study. Br J Cancer 2006, 95:1593-1597.
13. Dondog B, Clifford GM, Vaccarella S, et al. Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study. Cancer Epidemiol Biomarkers Prev 2008, 17:1731-1738.
14. Lazcano-Ponce E, Herrero R, Munoz N, et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer 2001, 91:412-420.
15. Matos E, Loria D, Amestoy GM, et al. Prevalence of human papillomavirus infection among women in Concordia, Argentina: a population-based study. Sex Transm Dis 2003, 30:593-599.
16. Molano M, Posso H, Weiderpass E, et al. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer 2002, 87:324-333.
17. Ferreccio C, Prado RB, Luzoro AV, et al. Population-based prevalence and age distribution of human papillomavirus among women in Santiago, Chile. Cancer Epidemiol Biomarkers Prev 2004, 13:2271-2276.
18. Thomas JO, Herrero R, Omigbodun AA, et al. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer 2004, 90:638-645.
19. de Sanjose S, Almirall R, Lloveras B, et al. Cervical human papillomavirus infection in the female population in Barcelona, Spain. Sex Transm Dis 2003, 30:788-793.
20. Bardin A, Vaccarella S, Clifford GM, et al. Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland. Eur J Cancer 2008, 44:557-564.
21. Hammouda D, Munoz N, Herrero R, et al. Cervical carcinoma in Algiers, Algeria: human papillomavirus and lifestyle risk factors. Int J Cancer 2005, 113:483-489.
22. Chaouki N, Bosch FX, Munoz N, et al. The viral origin of cervical cancer in Rabat, Morocco. Int J Cancer 1998, 75:546-554.
23. Bosch FX, Munoz N, de Sanjose S, et al. Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: a case-control study in Spain and Colombia. Cancer Epidemiol Biomarkers Prev 1993, 2:415-422.
24. Munoz N, Bosch FX, de Sanjose S, et al. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer 1992, 52:743-749.
25. Bosch FX, Munoz N, de Sanjose S, et al. Risk factors for cervical cancer in Colombia and Spain. Int J Cancer 1992, 52:750-758.
26. Franceschi S, Rajkumar T, Vaccarella S, et al. Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study. Int J Cancer 2003, 107:127-133.
27. Chichareon S, Herrero R, Munoz N, et al. Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst 1998, 90:50-57.
28. Ngelangel C, Munoz N, Bosch FX, et al. Causes of cervical cancer in the Philippines: a case-control study. J Natl Cancer Inst 1998, 90:43-49.
29. Hildesheim A, Schiffman MH, Gravitt PE, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994, 169:235-240.
30. Jacobs MV, Roda Husman AM, van den Brule AJ, Snijders PJ, Meijer CJ, Walboomers JM Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J Clin Microbiol 1995, 33:901-905.
31. Roda Husman AM, Walboomers JM, Meijer CJ, et al. Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes, using polymerase chain reaction. Int J Cancer 1994, 56:802-806.
32. van den Brule AJ, Snijders PJ, Raaphorst PM, et al. General primer polymerase chain reaction in combination with sequence analysis for identification of potentially novel human papillomavirus genotypes in cervical lesions. J Clin Microbiol 1992, 30:1716-1721.
33. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 1998, 36:3020-3027.
34. Moreno V, Bosch FX, Munoz N, et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet 2002, 359:1085-1092.
35. Smith JS, Green J, Berrington dG, et al. Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet 2003, 361:1159-1167.
36. Winer RL, Hughes JP, Feng Q, et al. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 2006, 354:2645-2654.
37. The Bethesda System for reporting cervical cytology: definitions, criteria, and explanatory notes 2004, Springer, New York. 2nd edn. D. Solomon, R. Nayar (Eds.).